Latest Issue of EPM
Sponsored Content
White Raven sets new standards for achieving GMP certification
Download the Playbook to learn how White Raven reached GMP certification in just 18 months.
European Pharmaceutical Manufacturer - Apr-Jun 2025
The Apr-Jun 2025 issue of European Pharmaceutical Manufacturer explores the latest sustainability in packaging trends, a Q&A with i-team Global, features on bioprocessing, process technologies and drug delivery, as well as a cover story from Tive.
European Pharmaceutical Manufacturer - Feb/Mar 2025
The Feb/Mar 2025 issue of European Pharmaceutical Manufacturer explores the latest packaging trends, a Q&A with FUJIFILM Diosynth Biotechnologies, Drug Delivery & Devices plus Biopharma and Manufacturing insights alongside NewAge Industries.
European Pharmaceutical Manufacturer - Nov/Dec 2024
The Nov/Dec 2024 issue of EPM Magazine explores the latest insights on regulations, manufacturing and testing & inspection, plus a cover story from Tower Cold Chain.
European Pharmaceutical Manufacturer - Sept/Oct 2024
The Sept/Oct 2024 issue of EPM Magazine explores the latest insights on regulations, digital health and coatings plus a cover story from SHL Medical.
European Pharmaceutical Manufacturer - May/June 2024
The May/June 2024 issue of EPM Magazine explores the latest insights on cell & gene therapy, bioprocessing, packaging and manufacturing plus the opinion from AstraZeneca and a cover story from Fette.
European Pharmaceutical Manufacturer - March/April 2024
The March/April 2024 issue of EPM Magazine explores the latest clinical trials insights, a Q&A with Lonza, how automation and robotics are shaping the future, analysing advancing clinical trials manufacturing from pilot to production and more!
European Pharmaceutical Manufacturer - Jan/Feb 2024
The Jan/Feb 2024 issue of European Pharmaceutical Manufacturer explores the latest packaging trends, a Q&A with Lonza, Drug Delivery & Devices, Sustainability, plus Biopharma and Manufacturing insights alongside Element Materials Technologies.
Sponsored Content
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00
Sponsored Content
White Raven sets new standards for achieving GMP certification
Download the Playbook to learn how White Raven reached GMP certification in just 18 months.
Sponsored Content
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00









